Tirzepatide (API)

Product Name：Tirzepatide peptide API

CAS NO：2023788-19-2

Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈

Molecular Weight: ~4813.5

Purity: ≥99% (by HPLC)

Appearance: White  powder

Grade: Pharmaceutical Grade / API Grade

Shelf Life: 24 months

Storage Condition: 2-8°C, protected from light, sealed storage

Packaging: 1g/bag, 5g/bag, 10g/bag, 100g/bag, or as customer's request

US DMF Status: #039900 (Active)

GMP Compliance: Manufactured under cGMP standards

Product Usage

Tirzepatide is a first-in-class dual agonist targeting the human GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. It is a synthetic 39-amino acid linear peptide conjugated to a C20 fatty diacid moiety, which enables high albumin binding and a prolonged half-life.

Tirzepatide uniquely combines the effects of both GIP and GLP-1 to enhance glucose-dependent insulin secretion while reducing appetite and food intake. It represents the next generation of incretin-based therapies beyond single agonists.

Clinical studies have demonstrated that tirzepatide significantly improves glycemic control and achieves substantial weight reduction. In Phase 3 clinical trials, patients taking tirzepatide experienced an average weight loss of 15-21% depending on the dose, with significant improvements in cardiometabolic risk factors.

Key Benefits:

• Dual GIP and GLP-1 receptor activation

• Once-weekly administration

• Significant HbA1c reduction (1.5-2.0%)

• Substantial weight loss (15-21% at higher doses)

• Improvements in blood pressure and lipid profile

How much weight can you expect to lose with tirzepatide?

Clinical trials have shown that patients taking tirzepatide achieved an average weight reduction of 15-21% over 72 weeks, depending on the dose, with the 15 mg dose showing the greatest efficacy.

FAQ

1. May I get a sample before placing an order?

Yes, samples are available. For regular products, samples are free of charge and you only need to bear the freight. For high-value products, you need to pay for the freight and a certain product cost. When we cooperate for some time or when you become our VIP customer, free samples will be offered when needed.

2. Which payment methods are available for your company?

T/T, PayPal, bank transfer, and other options. You can choose the one that is most convenient for you.

3. How and when can I get my goods after payment?

For small quantities, products will be delivered by international courier (DHL, FedEx, TNT, etc.) or by air. Usually, it takes 5-7 days to receive the goods after shipment. For large quantities, shipping by sea is more cost-effective. It takes 15-30 days to reach your destination port, depending on the port location.

4. Is it possible to use my own label or packaging?

Yes. If needed, we can accommodate custom labeling and packaging requirements. Please provide your specifications and we will confirm feasibility.

5. What is the purity and quality standard of your Tirzepatide API?

Our Tirzepatide API is manufactured under cGMP standards with purity ≥98% by HPLC. Higher purity (≥99%) is available upon request. We provide comprehensive documentation including COA, stability data, and DMF filing support.

6. What is the recommended storage condition?

Store at -20°C for long-term storage, or 4°C for up to 2 years. Protect from light and keep dry. The shelf life is 24 months under recommended storage conditions.

7. Do you provide regulatory support for filing?

Yes, we provide regulatory support including DMF filing assistance, documentation packages, and technical support for customer submissions.

Company Profile

Hangzhou ThinHeal Pharma-Tech Co., Ltd. (ThinHeal) is a high-tech enterprise specializing in the research, development, production, and sales of peptide products. The core management team is composed of professionals with a pharmaceutical background and nearly 20 years of management experience, positioning the company at the forefront of the industry.

The company has a complete and efficient peptide R&D, production, and sales system, and provides a full range of peptide industrialization services, including:

• Peptide API R&D and production business

• Peptide customized R&D and production (CDMO) business

• Beauty peptide research, development, and production business

The company's revenue is mainly derived from peptide API sales and CDMO services. The company has successfully completed US FDA DMF filings for multiple products. The CDMO business includes project-based entrusted research and development, entrusted production, and sales. The main customers of the CDMO business are innovative drug companies and scientific research institutions, among which some pharmaceutical companies have cooperated with ThinHeal since the product development stage and have established solid cooperative relationships.

ThinHeal is committed to providing high-quality peptide APIs and comprehensive technical support to customers worldwide, with a focus on regulatory compliance, supply chain reliability, and customer satisfaction.

Contact Us

For pricing, DMF status, sample requests, or technical inquiries regarding Tirzepatide API, please contact our sales team.